Browse All

Current Filters

CLEAR FILTER x

TITLE

Comparative Pharmacology of Ofatumumab vs Ocrelizumab in Humanized CD20 Transgenic Mice

Author:Bigaud, Marc   Anthony, Daniel   Zipfel, Geraldine   Uffelmann, Tatjana   Vostiarova, Helena   Engelhardt, Volker   Nuesslein-Hildesheim, Barbara   Kieseier, Bernd   

Session Name:S9: MS Biomarkers, Immunology, and Basic Science  

Topic:MS and Inflammatory Disease  

Program Number:S9.007  

Author Institution:Novartis Pharma AG, Basel, Switzerland  University of Oxford, Oxford, United Kingdom  

Remibrutinib Inhibits Neuroinflammation Driven by B Cells and Myeloid Cells in Preclinical Models of Multiple Sclerosis

Author:Kieseier, Bernd   Cenni, Bruno   Nuesslein-Hildesheim, Barbara   Ferrero, Enrico   Huck, Catherine   Eichlisberger, Denis   Ziehn, Marina   

Session Name:P2: MS Immunology and Basic Science  

Topic:MS and Inflammatory Disease  

Program Number:P2.013  

Author Institution:Novartis Pharma AG  Novartis Institutes for Biomedical Research